Akebia Therapeutics Inc Share Price Today: Live Updates & Key Insights
Akebia Therapeutics Inc share price today is $1.4, up 0%. The stock opened at $1.415 against the previous close of $1.42, with an intraday high of $1.455 and low of $1.395.
Akebia Therapeutics Inc Share Price Chart
Akebia Therapeutics Inc
Akebia Therapeutics Inc Share Price Performance
Akebia Therapeutics Inc Institutional Holdings
Akebia Therapeutics Inc Market Status
Akebia Therapeutics Inc Fundamentals
Market Cap 380.39 M
PB Ratio 11.6648
PE Ratio 0.0
Enterprise Value 247.34 M
Total Assets 376.57 M
Volume 7623383
Akebia Therapeutics Inc Company Financials
About Akebia Therapeutics Inc & investment objective
Company Information Akebia Therapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics for patients with kidney diseases. Its product portfolio includes Vafseo (vadadustat), an oral hypoxia-inducible factor prolyl hydroxylase, for the treatment of anemia due to chronic kidney disease (CKD) in dialysis-dependent (DD) and non-dialysis dependent (NDD) patients; and Auryxia, a ferric citrate that is used to control the serum phosphorus levels in adult patients with DD-CKD and the treatment of iron deficiency anemia in adult patients with NDD-CKD. The company is also developing AKB-9090, which is in Phase 2 clinical trial for treating cardiac surgery-related acute kidney injury and acute respiratory distress syndrome; and AKB-10108 for the treatment of retinopathy of prematurity in neonates. The company has license and collaboration agreements with Tanabe Pharma Corporation for the development and commercialization of Vafseo in Japan and other Asian countries; Vafseo License and Collaboration Agreements; CSL Vifor Agreements; Averoa License Agreement; License Agreement with Panion & BF Biotech, Inc.; Cyclerion Therapeutics License Agreement; and Q32 Asset Purchase Agreement. Akebia Therapeutics, Inc. was incorporated in 2007 and is headquartered in Cambridge, Massachusetts.
Organisation Drug Manufacturers - Specialty & Generic
Employees 194
Industry Drug Manufacturers - Specialty & Generic
CEO Mr. John P. Butler MBA
Trading and brokerage services provided by
Technology Services provided by Motilal Oswal Financial Services:
Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*
Take your next step
Akebia Therapeutics Inc FAQs
What is the share price of Akebia Therapeutics Inc today?
The current share price of Akebia Therapeutics Inc is $1.4.
Can I buy Akebia Therapeutics Inc shares in India?
Yes, Indian investors can buy Akebia Therapeutics Inc shares by opening an international trading and demat account with Motilal Oswal.
How to buy Akebia Therapeutics Inc shares in India?
You can easily invest in Akebia Therapeutics Inc shares from India by:
- Direct Investment:
Opening an international trading account with Motilal Oswal which includes KYC verification in the US. Your account gets activated in a few minutes to a few hours, after which you can start adding funds in USD balance to buy Akebia Therapeutics Inc shares. - Indirect Investment:
Under this form of investment, you can choose either a Mutual Fund (MF) or an Exchange-Traded Fund (ETF) that invests in global shares and start investing in shares of Akebia Therapeutics Inc.
Can I buy fractional shares of Akebia Therapeutics Inc?
Yes, many platforms allow you to buy fractional shares starting from as low as $1.
What is the market capitalization value of Akebia Therapeutics Inc?
Akebia Therapeutics Inc has a market cap of $380.39 M.
In which sector does Akebia Therapeutics Inc belong?
Akebia Therapeutics Inc operates in the Drug Manufacturers - Specialty & Generic sector.
What documents are required to invest in Akebia Therapeutics Inc stocks?
To invest, you typically need:
What is the PE and PB ratio of Akebia Therapeutics Inc?
The PE ratio of Akebia Therapeutics Inc is N/A and the PB ratio is 11.66.